Immucell (ICCC) Raw Materials (2018 - 2026)
Immucell's (ICCC) quarterly Raw Materials came in at $1.7 million in Q4 2025, up 21.72% YoY from $1.4 million in Q4 2024, and down 11.85% on a QoQ basis from $1.9 million in Q3 2025.
Immucell (ICCC) Raw Materials (2018 - 2026) Analysis & Trends
Immucell (ICCC) has 8 years of Raw Materials data on file, last reported at $1.7 million in Q4 2025.
- Quarterly Raw Materials rose 21.72% year-over-year to $1.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 million (up 21.72% YoY) and the FY2025 annual result came in at $1.7 million, up 21.72% from the prior year.
- Raw Materials fell to $1.7 million in Q4 2025, from $1.9 million in the prior quarter.
- In the past five years, Raw Materials ranged from a high of $2.4 million in Q4 2022 to a low of $660547.0 in Q1 2021.
- A 5-year average of $1.6 million and a median of $1.6 million in 2025 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2024 — Raw Materials slumped 44.29% — and 2025, when it surged 42.54%.
- Tracing ICCC's Raw Materials over 5 years: stood at $660547.0 in 2021, then soared by 266.36% to $2.4 million in 2022, then slumped by 34.13% to $1.6 million in 2023, then fell by 14.92% to $1.4 million in 2024, then advanced by 21.72% to $1.7 million in 2025.
- The last three Raw Materials figures came in at $1.7 million (Q4 2025), $1.9 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Immucell | 92.01 Mn | 83.15 Mn | 2.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.44 Mn |
| Dec 31, 2025 | 1.65 Mn |
| Sep 30, 2025 | 1.87 Mn |
| Jun 30, 2025 | 1.51 Mn |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 1.36 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 1.63 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Dec 31, 2022 | 2.42 Mn |
| Mar 31, 2021 | 660,547.00 |
| Dec 31, 2020 | 631,019.00 |
| Sep 30, 2020 | 575,629.00 |
| Jun 30, 2020 | 647,713.00 |
| Mar 31, 2020 | 590,720.00 |
| Dec 31, 2019 | 791,558.00 |
| Sep 30, 2019 | 686,740.00 |